ATHX

Athersys, Inc. News Headlines

$1.41
*  
0.03
2.08%
Get ATHX Alerts
*Delayed - data as of Sep. 19, 2014  -  Find a broker to begin trading ATHX now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time
Viewing
Filtered By
Ordered By

Synergy Pharma Prices Public Offering - Analyst Blog
4/12/2013 4:06:35 PM - Zacks.com

BMY to Expand Facility, Hire 350 - Analyst Blog
4/12/2013 10:50:01 AM - Zacks.com

Aeterna Zentaris/Ergomed Join Forces - Analyst Blog
4/11/2013 6:09:35 PM - Zacks.com

BioMarin Attains 52-Week High - Analyst Blog
4/11/2013 6:07:27 PM - Zacks.com

Alkermes Announces Restructuring Plan - Analyst Blog
4/11/2013 5:06:42 PM - Zacks.com

Synergy Pharma to Raise Funds - Analyst Blog
4/10/2013 6:10:09 PM - Zacks.com

Regeneron Rated Neutral Again - Analyst Blog
4/10/2013 5:57:01 PM - Zacks.com

Positive Data on PCYC's Ibrutinib - Analyst Blog
4/10/2013 5:09:09 PM - Zacks.com

Affymetrix to Disappoint in 1Q - Analyst Blog
4/10/2013 9:10:00 AM - Zacks.com

Sanofi Unveils Bond Issue Pricing - Analyst Blog
4/9/2013 4:08:12 PM - Zacks.com

AZN Reports Data on Fostamatinib - Analyst Blog
4/8/2013 7:08:59 PM - Zacks.com

ISIS Initiates ISIS-APOA Study - Analyst Blog
4/8/2013 6:09:14 PM - Zacks.com

QLT Sells PPDS Technology - Analyst Blog
4/5/2013 3:08:41 PM - Zacks.com

Orphan Status for Insmed's Arikace - Analyst Blog
4/4/2013 4:07:41 PM - Zacks.com

BioMarin Files CTA for BMN-190 - Analyst Blog
4/3/2013 10:22:52 AM - Zacks.com

Perrigo Touches 52-Week High - Analyst Blog
4/3/2013 9:23:05 AM - Zacks.com

Perrigo Buys Velcera - Analyst Blog
4/2/2013 5:24:35 PM - Zacks.com

BMRN Seeks US Approval of Vimizim - Analyst Blog
4/2/2013 4:17:57 PM - Zacks.com

Celgene Reaches 52-Week High - Analyst Blog
4/2/2013 10:08:11 AM - Zacks.com

Gilead's HCV Study to Continue - Analyst Blog
4/1/2013 5:05:01 PM - Zacks.com

Bad News for Alexion, Shares Down - Analyst Blog
4/1/2013 4:07:41 PM - Zacks.com

FDA Approves Biogen's Tecfidera - Analyst Blog
3/28/2013 7:27:01 PM - Zacks.com

Balanced View on Gilead Sciences - Analyst Blog
3/28/2013 6:26:33 PM - Zacks.com

Good News for Simcere Pharma - Analyst Blog
3/28/2013 5:28:59 PM - Zacks.com

Athersys, Inc. Has Blockbuster Potential
3/27/2013 4:56:00 PM - Seeking Alpha